BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19028421)

  • 1. No short-term benefits of antenatal corticosteroid treatment in severely preterm growth restricted fetuses: a case-control study.
    van Stralen G; van der Bos J; Lopriore E; Te Pas AB; Bloemenkamp KW; Walther FJ; Scherjon S
    Early Hum Dev; 2009 Apr; 85(4):253-7. PubMed ID: 19028421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antenatal corticosteroid therapy in premature infants.
    Smrcek JM; Schwartau N; Kohl M; Berg C; Geipel A; Krapp M; Diedrich K; Ludwig M
    Arch Gynecol Obstet; 2005 Jan; 271(1):26-32. PubMed ID: 15309401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is antenatal steroid treatment effective in preterm IUGR fetuses?
    Torrance HL; Derks JB; Scherjon SA; Wijnberger LD; Visser GH
    Acta Obstet Gynecol Scand; 2009; 88(10):1068-73. PubMed ID: 19670049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antenatal predictors of neonatal outcome in fetal growth restriction with absent end-diastolic flow in the umbilical artery.
    Vergani P; Roncaglia N; Locatelli A; Andreotti C; Crippa I; Pezzullo JC; Ghidini A
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1213-8. PubMed ID: 16157140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a single dose of antenatal corticosteroids on morbidity and mortality of preterm infants.
    Costa S; Zecca E; De Luca D; De Carolis MP; Romagnoli C
    Eur J Obstet Gynecol Reprod Biol; 2007 Apr; 131(2):154-7. PubMed ID: 16797825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contraction stress test versus ductus venosus Doppler evaluation for the prediction of adverse perinatal outcome in growth-restricted fetuses with non-reassuring non-stress test.
    Figueras F; Martínez JM; Puerto B; Coll O; Cararach V; Vanrell JA
    Ultrasound Obstet Gynecol; 2003 Mar; 21(3):250-5. PubMed ID: 12666219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of the neonatal lung immaturity].
    Zhekova N; Mikhova M; Nikolov A; Dimitrov A
    Akush Ginekol (Sofiia); 2009; 48(1):11-5. PubMed ID: 19496457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of single or multiple courses of antenatal corticosteroid therapy on neonatal respiratory distress syndrome in singleton versus twin pregnancies.
    Choi SJ; Song SE; Seo ES; Oh SY; Kim JH; Roh CR
    Aust N Z J Obstet Gynaecol; 2009 Apr; 49(2):173-9. PubMed ID: 19432606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential risks and benefits of antenatal corticosteroid therapy prior to preterm birth in pregnancies complicated by severe fetal growth restriction.
    Vidaeff AC; Blackwell SC
    Obstet Gynecol Clin North Am; 2011 Jun; 38(2):205-14, ix. PubMed ID: 21575796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single versus multiple courses of antenatal betamethasone and neonatal outcome: a randomized controlled trial.
    Mazumder P; Dutta S; Kaur J; Narang A
    Indian Pediatr; 2008 Aug; 45(8):661-7. PubMed ID: 18723909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple courses of antenatal corticosteroid therapy in patients with preterm premature rupture of membranes.
    Yang SH; Choi SJ; Roh CR; Kim JH
    J Perinat Med; 2004; 32(1):42-8. PubMed ID: 15008385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of respiratory disorders in neonates born between 34 and 36 weeks of gestation following exposure to antenatal corticosteroids between 24 and 34 weeks of gestation.
    Ventolini G; Neiger R; Mathews L; Adragna N; Belcastro M
    Am J Perinatol; 2008 Feb; 25(2):79-83. PubMed ID: 18188800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between abnormal fetal testing and adverse perinatal outcomes in intrauterine growth restriction.
    Gonzalez JM; Stamilio DM; Ural S; Macones GA; Odibo AO
    Am J Obstet Gynecol; 2007 May; 196(5):e48-51. PubMed ID: 17466679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal outcome in preterm deliveries between 23 and 27 weeks' gestation with and without preterm premature rupture of membranes.
    Newman DE; Paamoni-Keren O; Press F; Wiznitzer A; Mazor M; Sheiner E
    Arch Gynecol Obstet; 2009 Jul; 280(1):7-11. PubMed ID: 19031080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perinatal risk factors for neonatal intracerebral hemorrhage in preterm infants.
    Ertan AK; Tanriverdi HA; Meier M; Schmidt W
    Eur J Obstet Gynecol Reprod Biol; 2006 Jul; 127(1):29-34. PubMed ID: 16815469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of antenatal corticosteroids on fetal growth, survival, and neurodevelopmental outcome in triplet pregnancies.
    D'Amore A; Ahluwalia J; Cheema I; Prentice A; Kaptoge S; Kelsall W
    Am J Perinatol; 2004 Jan; 21(1):1-8. PubMed ID: 15017475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a 'rescue course' of antenatal corticosteroids: a multicenter randomized placebo-controlled trial.
    Garite TJ; Kurtzman J; Maurel K; Clark R;
    Am J Obstet Gynecol; 2009 Mar; 200(3):248.e1-9. PubMed ID: 19254583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antenatal glucocorticoid treatment of the growth-restricted fetus: benefit or cost?
    Morrison JL; Orgeig S
    Reprod Sci; 2009 Jun; 16(6):527-38. PubMed ID: 19276405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of antenatal corticosteroids in special circumstances: a comprehensive review.
    Magann EF; Haram K; Ounpraseuth S; Mortensen JH; Spencer HJ; Morrison JC
    Acta Obstet Gynecol Scand; 2017 Apr; 96(4):395-409. PubMed ID: 28130929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Indication of corticotherapy for fetal pulmonary maturation].
    Tchobroutsky C
    Contracept Fertil Sex; 1996 May; 24(5):413-6. PubMed ID: 8704822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.